Montelukast Stada

Montelukast, the active ingredient in Montelukast Stada, is a leukotriene receptor antagonist presented as a tablet for oral use. It treats asthma, allergic rhinitis and exercise‑induced bronchoconstriction in adults and children.\n\nGNH India supplies Montelukast Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast is a leukotriene receptor antagonist used to manage respiratory and allergic conditions.\n\nAsthma: reduces symptom frequency and improves lung function.\nAllergic rhinitis: alleviates nasal congestion, sneezing and itching.\nExercise‑induced bronchoconstriction: prevents airway narrowing triggered by physical activity.

Montelukast may cause a range of adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Headache\n- Abdominal pain\n- Cough\n- Nausea\n\nSerious or Rare Side Effects:\n- Allergic reactions such as rash or angioedema\n- Mood changes including depression or suicidal thoughts\n- Hepatic injury or elevated liver enzymes

When prescribing Montelukast, clinicians should consider several safety aspects.\n\nPregnancy: safety not established; consult a healthcare provider.\nBreastfeeding: unknown; weigh benefits against potential risks.\nRenal or hepatic impairment: use with caution and monitor.\nConcomitant antidepressants: monitor for mood alterations.\nDrug interactions: review all co‑administered medicines.\nStore at room temperature: keep in the original container, protect from moisture and heat.

Montelukast can interact with other medicines, affecting its efficacy or safety.\n\nMajor Interactions (Avoid):\n- Ritonavir: may increase montelukast plasma levels.\n- Phenobarbital: may reduce montelukast effectiveness.\n- Carbamazepine: may lower montelukast concentrations.\n\nModerate Interactions (Monitor Closely):\n- Fluconazole: may modestly raise montelukast levels.\n- Warfarin: monitor INR as montelukast can influence metabolism.